Eurand is a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products using our innovative drug delivery technologies. The Company’s drug development efforts are based on three commercialised technology platforms; bioavailability enhancement of poorly soluble drugs, customized release and taste masked/fast dissolving formulations. Eurand has recently added a fourth technology platform, drug targeting, to its capabilities that, once commercialised, can be applied to small molecule and biotechnology derived products for improved drug delivery.
Eurand is dedicated to the continued development and commercialisation of breakthrough technologies and products that better satisfy patients’ needs. To this end, the Company develops treatment options with superior safety, enhanced efficacy and convenient dosing.
Corporate Locations - United States
845 Center Drive
Vandalia, Ohio 45377
USA
Tel: +1 937 898 9669
Fax: +1 937 898 9529
48 Wall Street
32nd Floor
New York, NY 10005
USA
Tel: +1 212 389 5770
Fax: +1 212 389 5780
Italy
Via M. Luther King, 13
20060 - Pessano con Bornago
(Milan) Italy
Tel: +39 02 954281
Fax: +39 02 95745018/12
Via Molise, 16
20098 San Giuliano Milanese
(Milan) Italy
Tel: +39 02 988981
Fax: +39 02 98281706
Stabilimento di Trieste
Via del Follatoio 12
34148 - Trieste
Tel: + 39 040 8992239
Fax: + 39 040 8992243
France
14, Rue de Clos Barrois
Z.I. de Nogent-Oise 60183
Nogent Cedex-France
Tel: +33 3 4455 3682
Fax: +33 3 4455 2260
Website: www.eurand.com